The microbial-derived metabolite trimethylamine N-oxide (TMAO) increases β-secretase activity and Aβ accumulation, and plasma TMAO levels were associated with deteriorative cognitive functions and AD pathology in APP/PS1 mice [134]. This evidence concerns the gene APP and Alzheimer disease.